Tert-butyl (2-oxo-2,3-dihydrobenzimidazol-1-yl)acetate → [3-(2-Methoxy-2-oxoethyl)-4,6-dimethyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl]acetic acid
反応式
O=C1N(CC(OC(C)(C)C)=O)C2C=CC=CC=2N1.[CH3:19][O:20][C:21](=[O:43])[CH2:22][N:23]1[C:27]2[C:28]([CH3:33])=[CH:29][C:30]([CH3:32])=[CH:31][C:26]=2[N:25]([CH2:34][C:35]([O:37]C(C)(C)C)=[O:36])[C:24]1=[O:42]>>[CH3:19][O:20][C:21](=[O:43])[CH2:22][N:23]1[C:27]2[C:28]([CH3:33])=[CH:29][C:30]([CH3:32])=[CH:31][C:26]=2[N:25]([CH2:34][C:35]([OH:37])=[O:36])[C:24]1=[O:42]参加物
3
実験手順
Essentially following the procedures described for Intermediate 7, but using tert-butyl [3-(2-methoxy-2-oxoethyl)-4,6-dimethyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl]acetate from Step C in place of tert-butyl (2-oxo-3-pyridin-2-yl-2,3-dihydro-1H-benzimidazol-1-yl)acetate, the title compound was prepared. MS: m/z=293 (M+1).
出典と根拠
- ORDレコード
- ord-2f7ad425050048c781cf78d178db65a1
- 出典データセット
- uspto-grants-2012_05
- 特許番号
- US08173655B2
反応ノート
読み込み中…